Published in Blood Weekly, October 23rd, 2003
IDN-6556 is a drug intended to protect liver cells (hepatocytes) from excessive programmed cell death, also known as apoptosis. Excessive apoptosis has been implicated in many different liver diseases and conditions. Idun believes that IDN-6556 will be beneficial in the treatment of the injury that occurs during liver transplantation procedures.
Orphan drug designation will apply to the treatment of patients with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.